SWOG clinical trial number
SWOG-8717

Evaluation of Amonafide and Didemnin-B in the Treatment of Ovarian Cancer

Closed
Phase
Accrual
63%
Published
Abbreviated Title
Evaluation of Amonafide and Didemnin-B in the Treatment of Ovarian Cancer
Activated
05/15/1988

Publication Information Expand/Collapse

1992

Phase II trial of didemnin-B in advanced epithelial ovarian cancer. A Southwest Oncology Group study.

JM Cain;PY Liu;DS Alberts;HH Gallion;L Laufman;J O'Sullivan;G Weiss;G Mills IND 10:23-24

Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: A Southwest Oncology Group study.

HH Gallion;PY Liu;DS Alberts;RV O'Toole;J O'Sullivan;G Mills;HO Smith;HE Hynes Gyn Onc 46:230-232